Format
Sort by

Send to

Choose Destination

Selected items

Items: 4

1.

Sipuleucel-T: APC 8015, APC-8015, prostate cancer vaccine--Dendreon.

[No authors listed]

Drugs R D. 2006;7(3):197-201. Review.

PMID:
16752945
2.

Technology evaluation: APC-8015, Dendreon.

Rini BI.

Curr Opin Mol Ther. 2002 Feb;4(1):76-9. Review.

PMID:
11883698
3.

Dendreon vs CMS: why the Provenge coverage controversy is bigger than just one product.

Baghdadi R.

Oncology (Williston Park). 2010 Sep;24(10):881-3. No abstract available.

4.

Technology evaluation: APC-80200, Dendreon.

Rice A, Hart D.

Curr Opin Mol Ther. 2002 Oct;4(5):523-7.

PMID:
12435055

Supplemental Content

Support Center